Cargando…
Do DLX3 and CD271 Protect Human Keratinocytes from Squamous Tumor Development?
Well-regulated epidermal homeostasis depends on the function of different classes of factors, such as transcription regulators and receptors. Alterations in this homeostatic balance may lead to the development of cutaneous squamous tumorigenesis. The homeobox transcription factor DLX3 is determinant...
Autores principales: | Palazzo, Elisabetta, Marconi, Alessandra, Pincelli, Carlo, Morasso, Maria I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678400/ https://www.ncbi.nlm.nih.gov/pubmed/31331058 http://dx.doi.org/10.3390/ijms20143541 |
Ejemplares similares
-
CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes
por: Quadri, Marika, et al.
Publicado: (2023) -
Isolation of an “Early” Transit Amplifying Keratinocyte Population in Human Epidermis: A Role for the Low Affinity Neurotrophin Receptor CD271
por: Lotti, Roberta, et al.
Publicado: (2022) -
Molecular Approach to Cutaneous Squamous Cell Carcinoma: From Pathways to Therapy
por: Palazzo, Elisabetta, et al.
Publicado: (2020) -
A novel DLX3–PKC integrated signaling network drives keratinocyte differentiation
por: Palazzo, Elisabetta, et al.
Publicado: (2017) -
The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth
por: Palazzo, Elisabetta, et al.
Publicado: (2015)